CLINICAL_TRIALS
trial_result
· 2014-12-08
Clinical Trial Update: Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial [Phase 4]
Summary
Phase 4 clinical trial update for HALO evaluating effects in HIV-related arterial dysfunction and lipids; completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tufts University | Conditions: Cardiovascular Disease, HIV Infection | Phase 4 | Status: COMPLETED | Results posted: 2014-12-08